Open AccessMetformin may reduce oral cancer risk in patients with type 2 diabetes
Author(s) -
ChinHsiao Tseng
Publication year - 2015
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.6626
Subject(s) - metformin , medicine , hazard ratio , confidence interval , proportional hazards model , propensity score matching , cancer , diabetes mellitus , cumulative dose , type 2 diabetes , endocrinology
Whether metformin use may affect the risk of oral cancer required further investigation.